Skip to main content
. 2005 Jan 24;2005(1):CD004096. doi: 10.1002/14651858.CD004096.pub2

Vargas 1994.

Methods Vargas 1994Multiple pub:No
Participants Study design: RCTRandomization procedure: NRAllocation concealment: UnclearFollow‐up: 12w
Interventions Country: USASetting: NRNumber: 18Age: NRSex: NRMedications: BRBL wt: NRBL BMI: NRBL GHb: NR
Outcomes Drug: SibutramineDosage: 20‐30mg qdDuration: 12wDiet: NRComparison: Placebo
Notes Weight: YesBMI:>5% loss (%):FBS: YesGHb:Cholesterol:LDL:HDL:TG:SBP:DBP:Side effects:
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment? Unclear risk B ‐ Unclear